University of Hohenheim   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Stuttgart Germany (1818)

Organization Overview

First Clinical Trial
2011
NCT01421979
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Department of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany | University of Hohenheim | University of Hohenheim, 70599 Stuttgart | University of Hohenheim, 70599 Stuttgart, Germany | University of Hohenheim, Stuttgart, Germany

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colorectal Neoplasms (Phase 3)

Metabolic Syndrome (Phase 2)

Stomach Neoplasms (Phase 3)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 19
  • # of Trial APIs: 23